Literature DB >> 17609281

Phase-dependent immune evasion of herpesviruses.

Tal Vider-Shalit1, Vered Fishbain, Shai Raffaeli, Yoram Louzoun.   

Abstract

Viruses employ various modes to evade immune detection. Two possible evasion modes are a reduction of the number of epitopes presented and the mimicry of host epitopes. The immune evasion efforts are not uniform among viral proteins. The number of epitopes in a given viral protein and the similarity of the epitopes to host peptides can be used as a measure of the viral attempts to hide this protein. Using bioinformatics tools, we here present a genomic analysis of the attempts of four human herpesviruses (herpes simplex virus type 1-human herpesvirus 1, Epstein-Barr virus-human herpesvirus 4, human cytomegalovirus-human herpesvirus 5, and Kaposi's sarcoma-associated herpesvirus-human herpesvirus 8) and one murine herpesvirus (murine herpesvirus 68) to escape from immune detection. We determined the full repertoire of CD8 T-lymphocyte epitopes presented by each viral protein and show that herpesvirus proteins present many fewer epitopes than expected. Furthermore, the epitopes that are presented are more similar to host epitopes than are random viral epitopes, minimizing the immune response. We defined a score for the size of the immune repertoire (the SIR score) based on the number of epitopes in a protein. The numbers of epitopes in proteins expressed in the latent and early phases of infection were significantly smaller than those in proteins expressed in the lytic phase in all tested viruses. The latent and immediate-early epitopes were also more similar to host epitopes than were lytic epitopes. A clear trend emerged from the analysis. In general, herpesviruses demonstrated an effort to evade immune detection. However, within a given herpesvirus, proteins expressed in phases critical to the fate of infection (e.g., early lytic and latent) evaded immune detection more than all others. The application of the SIR score to specific proteins allows us to quantify the importance of immune evasion and to detect optimal targets for immunotherapy and vaccine development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609281      PMCID: PMC1951411          DOI: 10.1128/JVI.02636-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Population of the HLA ligand database.

Authors:  M Sathiamurthy; H D Hickman; J W Cavett; A Zahoor; K Prilliman; S Metcalf; M Fernandez Vina; W H Hildebrand
Journal:  Tissue Antigens       Date:  2003-01

2.  MHCBN: a comprehensive database of MHC binding and non-binding peptides.

Authors:  Manoj Bhasin; Harpreet Singh; G P S Raghava
Journal:  Bioinformatics       Date:  2003-03-22       Impact factor: 6.937

3.  MPID: MHC-Peptide Interaction Database for sequence-structure-function information on peptides binding to MHC molecules.

Authors:  Kunde Ramamoorthy Govindarajan; Pandjassarame Kangueane; Tin Wee Tan; Shoba Ranganathan
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

4.  Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

Authors:  K C Parker; M A Bednarek; L K Hull; U Utz; B Cunningham; H J Zweerink; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

Review 5.  Herpesviruses--immune escape artists?

Authors:  T A Banks; B T Rouse
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

6.  Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.

Authors:  Elodie Ghedin; Naomi A Sengamalay; Martin Shumway; Jennifer Zaborsky; Tamara Feldblyum; Vik Subbu; David J Spiro; Jeff Sitz; Hean Koo; Pavel Bolotov; Dmitry Dernovoy; Tatiana Tatusova; Yiming Bao; Kirsten St George; Jill Taylor; David J Lipman; Claire M Fraser; Jeffery K Taubenberger; Steven L Salzberg
Journal:  Nature       Date:  2005-10-05       Impact factor: 49.962

7.  MHCPEP, a database of MHC-binding peptides: update 1997.

Authors:  V Brusic; G Rudy; L C Harrison
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

Review 8.  Escape of human immunodeficiency virus from immune control.

Authors:  A J McMichael; R E Phillips
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

9.  Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.

Authors:  Tracy Jo Pasieka; Tracey Baas; Victoria S Carter; Sean C Proll; Michael G Katze; David A Leib
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

10.  CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.

Authors:  Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

View more
  23 in total

1.  Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins.

Authors:  Tomer Hertz; David Nolan; Ian James; Mina John; Silvana Gaudieri; Elizabeth Phillips; Jim C Huang; Gonzalo Riadi; Simon Mallal; Nebojsa Jojic
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

2.  Viral CD8 T cell epitope nucleotide composition shows evidence of short- and long-term evolutionary strategies.

Authors:  Yaakov Maman; Uri Hershberg; Yoram Louzoun
Journal:  Immunogenetics       Date:  2014-11-08       Impact factor: 2.846

3.  The limited benefit of "product-by-process" claim.

Authors:  Bao-Chi Chang; Shyh-Jen Wang
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

4.  Optimal viral immune surveillance evasion strategies.

Authors:  Alexandra Agranovich; Tal Vider-Shalit; Yoram Louzoun
Journal:  Theor Popul Biol       Date:  2011-09-02       Impact factor: 1.570

5.  Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development.

Authors:  Riva Kovjazin; Ilan Volovitz; Yair Daon; Tal Vider-Shalit; Roy Azran; Lea Tsaban; Lior Carmon; Yoram Louzoun
Journal:  Mol Immunol       Date:  2011-02-12       Impact factor: 4.407

6.  Human self-protein CD8+ T-cell epitopes are both positively and negatively selected.

Authors:  Michal Almani; Shai Raffaeli; Tal Vider-Shalit; Lea Tsaban; Vered Fishbain; Yoram Louzoun
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

7.  Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells.

Authors:  Gautam R Bedadala; Rajeswara C Pinnoji; Jayavardhana R Palem; Shao-Chung V Hsia
Journal:  Cell Res       Date:  2010-04-13       Impact factor: 25.617

8.  Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.

Authors:  Ehud Hoze; Lea Tsaban; Yaakov Maman; Yoram Louzoun
Journal:  J Immunol Methods       Date:  2013-02-26       Impact factor: 2.303

9.  Immunological evasion of immediate-early varicella zoster virus proteins.

Authors:  Pieter Meysman; Dmitry Fedorov; Viggo Van Tendeloo; Benson Ogunjimi; Kris Laukens
Journal:  Immunogenetics       Date:  2016-03-29       Impact factor: 2.846

10.  Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis.

Authors:  Tal Vider-Shalit; Ronit Sarid; Kobi Maman; Lea Tsaban; Ran Levi; Yoram Louzoun
Journal:  Bioinformatics       Date:  2009-06-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.